| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |